Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicinal composition for treating type II diabetes mellitus and preparation method thereof

A type 2 diabetes mellitus and composition technology, applied in the field of pharmaceutical compositions and their preparation, can solve the problems of side effects, unclear mechanism, inaccurate curative effect, etc., and achieve the effects of alleviating inflammatory state and reducing fasting

Active Publication Date: 2012-09-19
YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Generally speaking, Western medicine has definite curative effect and clear mechanism, but there are various side effects
Although traditional Chinese medicine has the advantages of treating both symptoms and root causes, safety, and few side effects, it has shortcomings such as indefinite curative effect and unclear mechanism.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating type II diabetes mellitus and preparation method thereof
  • Medicinal composition for treating type II diabetes mellitus and preparation method thereof
  • Medicinal composition for treating type II diabetes mellitus and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Raw materials are weighed according to the following weight ratio:

[0050] 10 parts of Astragalus, 10 parts of Ganoderma lucidum, 10 parts of Ligustrum lucidum, and 10 parts of dark plum.

[0051] Take the above medicines, add 6 times of water and decoct twice, the first time for 3 hours, the second time for 2 hours, combine the decoctions of each component, filter, and concentrate the filtrate to a relative density of 1.2, add ethanol, stir well, Stand still, take the supernatant to recover ethanol, concentrate into extract, spray dry to obtain extract powder, add appropriate amount of pharmaceutical auxiliary materials except sucrose, mix well, and granulate to obtain the granular treatment type 2 of the present invention. Diabetes pharmaceutical composition. Three times a day, 4 capsules each time.

Embodiment 2

[0053] Raw materials are weighed according to the following weight ratio:

[0054] 30 parts of Astragalus, 10 parts of Ganoderma lucidum, 15 parts of Ligustrum lucidum, and 10 parts of dark plum.

[0055] Take the above medicines, add 6 times of water and decoct twice, the first time for 3 hours, the second time for 2 hours, combine the decoction, filter, the filtrate is concentrated to the extract, and spray-dried to obtain the extract powder, which is packed into capsules. Obtain the capsule-type pharmaceutical composition for treating type 2 diabetes described in the present invention. Three times a day, 4 capsules each time.

Embodiment 3

[0057] Raw materials are weighed according to the following weight ratio:

[0058] 30 parts of Astragalus, 30 parts of Ganoderma lucidum, 15 parts of Ligustrum lucidum, and 15 parts of dark plum.

[0059] Take the above medicines, wash and remove impurities from the raw materials, grind them into fine powder after drying, pass through a 100-200 mesh sieve, mix evenly, and finally fill capsules to obtain the capsule-type pharmaceutical composition for treating type 2 diabetes of the present invention. Three times a day, 4 capsules each time.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicinal composition for treating type II diabetes mellitus and a preparation method thereof. The medicinal composition comprises the following components in part by weight: 10 to 60 parts of astragalus, 10 to 100 parts of glossy ganoderma, 5 to 30 parts of glossy privet fruit and 6 to 30 parts of dark plum fruit. The medicinal composition of the invention can reduce fasting blood glucose and postprandial blood glucose and glycated hemoglobin effectively and relieve inflammation symptoms effectively, and has the good improved effect on the insulin resistance of patients who suffer from the type II diabetes mellitus.

Description

technical field [0001] The invention relates to a pharmaceutical composition and a preparation method thereof, in particular to a pharmaceutical composition for treating type 2 diabetes and a preparation method thereof. Background technique [0002] Diabetes (Diabetes Mellitus) is a metabolic disorder characterized by chronic hyperglycemia caused by a variety of etiologies. It is the third disease with the highest mortality and disability after cardiovascular and cerebrovascular diseases and cancer. In recent years, with the improvement of people's living standards, overnutrition, and reduced exercise, the incidence of diabetes is increasing year by year. It has become a disease that seriously affects human health and brings a huge economic burden to society. Type 2 diabetes is caused by low B cell function, relative lack of insulin and insulin resistance (Insulin Resistance, IR), which manifests as abnormally high glucose concentration in the blood circulation, and leads to...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/736A61P3/10
Inventor 杨宏杰张丹郑敏范朝华李昀昊
Owner YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products